Source comparison
BPC-157 Legal to Purchase for Research: Comparison
University laboratory purchasing from FDA-registered chemical supplier for in vitro cell studies Legal. Falls under research exemption (21 CFR 312.2) FDA-registered GMP-certified peptide manufacturer Institutional purchase order, research protocol, CoA with HP
This comparison does not assign a generated winner or score.
- University laboratory purchasing from FDA-registered chemical supplier for in vitro cell studies
- Legal. Falls under research exemption (21 CFR 312.2)
- FDA-registered GMP-certified peptide manufacturer
- Institutional purchase order, research protocol, CoA with HPLC purity ≥98%
- This is the compliance standard. Proper research use with full regulatory transparency
- Individual purchasing from online vendor labeled 'for research only' but marketed with therapeutic language
- Gray area. Peptide itself legal, but marketing violates FDA drug promotion rules
- Unregistered peptide reseller sourcing from overseas manufacturers
- None. Accepts consumer credit cards and ships without verification
- Most peptide purchases fall here. The product is real, the transaction is quasi-legal, and enforcement is inconsistent
- Individual purchasing pre-mixed syringes or vials with dosing instructions for 'personal research'
- Illegal. Constitutes drug distribution without approval
- Black-market operator violating FDA drug marketing statutes
- None. Anonymous cryptocurrency payments, international shipping
- This is unambiguous FDA violation. The framing is therapeutic, not research-oriented
- Physician prescribing or compounding BPC-157 for patient administration
- Illegal. BPC-157 is not FDA-approved for any therapeutic use and cannot be compounded under 503A or 503B exemptions
- Compounding pharmacy or prescribing physician
- None. BPC-157 does not qualify for compounding exemptions
- State medical boards have issued warnings and license suspensions for this. It is not off-label prescribing, it is prescribing an unapproved drug